The Manila Times

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II ...

Patients Enrolled Ahead of Plan in Pivotal Study Evaluating Symphony™ IL-6 for Early Assessment of 28-Day Sepsis Mortality Risk ...